Drug Type mRNA |
Synonyms XPACE 1005, XPACE1005 |
Target |
Action agonists |
Mechanism IgA1 agonists(Immunoglobulin A1 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
IgA Deficiency | Preclinical | United States | 01 Mar 2025 |